Tvax Biomedical Inc.
Lenexa, KS
- UEI
- CVL9JLC9BNR9
- CAGE
- 7RJ76
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
- Lenexa, KS GA81NAY8K5B7
-
- SAM.gov registration date
- Physical address
- 10049 Lakeview Ave, Lenexa, KS 66219, USA
- Website
- tvaxbiomedical.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Neoantigen-specific adoptive t cell therapy for glioblastoma, IND-BB-13135, protocol submitted 04/25/2020 - tvax… | FDA Office of Acquisition and Grant Services | $1,164,182 |
Quick answers
Is Tvax Biomedical Inc. registered in SAM.gov?
Yes. Tvax Biomedical Inc.'s SAM.gov registration is active through August 3, 2027.
What is Tvax Biomedical Inc.'s most recent federal award?
Tvax Biomedical Inc.'s most recent federal grant award is Neoantigen-specific adoptive t cell therapy for glioblastoma, IND-BB-13135, protocol submitted 04/25/2020 - tvax… (R01FD007259), from FDA Office of Acquisition and Grant Services, on September 20, 2022.
On GovTribe
See Tvax Biomedical Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors